Data / Form D filings / Kytopen Corp.
Kytopen Corp.: Form D filings
Kytopen Corp., a biotechnology company in Cambridge, MA, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on February 20, 2025, reports $7.1 million sold of a $15 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 750 MAIN STREET, Cambridge, MA, 02139
- Phone
- (617) 299-1688
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1777277
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | New notice | $15,000,107 | $7,082,651 | $7,917,456 | 13 | Feb 6, 2025 | sec.gov |
| Feb 15, 2024 | New notice | $8,000,000 | $5,691,637 | $2,308,363 | 22 | Jan 31, 2024 | sec.gov |
| Oct 8, 2021 | New notice | $32,479,963 | $32,479,963 | 18 | Sep 27, 2021 | sec.gov | |
| Nov 6, 2020 | New notice | $4,000,000 | $3,102,983 | $897,017 | 11 | Oct 26, 2020 | sec.gov |
| May 24, 2019 | New notice | $4,350,000 | $4,350,000 | 9 | May 10, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cullen Buie | Director | |
| Julio Vega | Executive Officer | |
| Michael Chiu | Director, Executive Officer | |
| Paul Wotton | Director | |
| Paxton Major | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Feb 17, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kytopen Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.